Nutralife Biosciences Inc (NLBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25 | 27 | N/A | 105 | 63 |
| Receivables | 2 | 13 | N/A | 11 | 35 |
| Inventories | 70 | 274 | N/A | 297 | 275 |
| TOTAL | $97 | $314 | $N/A | $413 | $373 |
| Non-Current Assets | |||||
| PPE Net | 249 | 262 | N/A | 284 | 274 |
| TOTAL | $249 | $262 | $N/A | $284 | $274 |
| Total Assets | $346 | $576 | $N/A | $697 | $648 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 828 | 648 | N/A | 498 | 473 |
| Accounts payable and accrued liabilities | 34 | 27 | 0 | 43 | 110 |
| Accrued Expenses | 236 | 104 | N/A | 58 | 41 |
| TOTAL | $1,295 | $898 | $N/A | $733 | $719 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,295 | $898 | $N/A | $733 | $719 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 22,282 | 22,222 | 21,802 | 21,802 | N/A |
| Common Shares | 2 | 2 | N/A | 2 | 2 |
| Retained earnings | -4,857 | -4,098 | N/A | -3,061 | -2,781 |
| TOTAL | $-949 | $-323 | $N/A | $-36 | $-71 |
| Total Liabilities And Equity | $346 | $576 | $0 | $697 | $648 |